Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Comparison of long-term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis.

Kubo S, Kadota K, Ichinohe T, Miyake K, Hyodo Y, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Fujii S, Goto T, Mitsudo K.

Circ J. 2014;78(1):101-9. Epub 2013 Nov 2.

2.

Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary intervention: a report from the VA CART program.

Armstrong EJ, Maddox TM, Carey EP, Grunwald GK, Shunk KA.

Am Heart J. 2014 Oct;168(4):560-7. doi: 10.1016/j.ahj.2014.07.020. Epub 2014 Jul 30.

PMID:
25262267
3.

Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).

Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, Nishimura E, Isshiki T; RESTART Investigators.

Circulation. 2010 Jul 6;122(1):52-61. doi: 10.1161/CIRCULATIONAHA.109.903955. Epub 2010 Jun 21.

4.
6.

Long-term clinical outcomes after angiographically defined very late stent thrombosis of drug-eluting stent.

Kim U, Kim DK, Kim YB, Seol SH, Yang TH, Kim DK, Kim DI, Kim DS, Lee SH, Hong GR, Park JS, Shin DG, Kim YJ, Cho YK, Kim HS, Nam CW, Hur SH, Kim KB.

Clin Cardiol. 2009 Sep;32(9):526-9. doi: 10.1002/clc.20648.

7.

Incidence and very long- term outcomes of stent thrombosis after bare-metal or drug-eluting stent implantation: a retrospective analysis.

Pullara A, Longo G, Gonella A, D'Ascenzo F, Biondi Zoccai G, Moretti C, Sciuto F, Omedè PL, Bollati M, Gaita F, Sheiban I.

Minerva Cardioangiol. 2013 Feb;61(1):1-9.

PMID:
23381375
8.

Identification of Intrastent Pathology Associated With Late Stent Thrombosis Using Optical Coherence Tomography.

Jones CR, Khandhar SJ, Ramratnam M, Mulukutla SR, Marroquin OC, Althouse AD, Rao A, Kato K, Jang IK, Toma C.

J Interv Cardiol. 2015 Oct;28(5):439-48. doi: 10.1111/joic.12220. Epub 2015 Sep 18.

PMID:
26381509
9.

Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.

Jones DA, Rathod KS, Gallagher S, Weerackody R, Knight CJ, Rothman MT, Mathur A, Jain AK, Timmis AD, Wragg A.

Catheter Cardiovasc Interv. 2013 May;81(6):E237-44. doi: 10.1002/ccd.24513. Epub 2012 Nov 14.

PMID:
22707383
10.

Bare metal stent thrombosis and in-stent neoatherosclerosis.

Yamaji K, Inoue K, Nakahashi T, Noguchi M, Domei T, Hyodo M, Soga Y, Shirai S, Ando K, Kondo K, Sakai K, Iwabuchi M, Yokoi H, Nosaka H, Nobuyoshi M, Kimura T.

Circ Cardiovasc Interv. 2012 Feb 1;5(1):47-54. doi: 10.1161/CIRCINTERVENTIONS.111.964965. Epub 2012 Jan 17.

11.

Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.

Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.

Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578.

12.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.

Kaltoft A, Kelbaek H, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

J Am Coll Cardiol. 2010 Aug 17;56(8):641-5. doi: 10.1016/j.jacc.2010.05.009.

13.

Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.

Ma HY, Zhou YJ, Dick RJ, Shi DM, Liu YY, Cheng WJ, Guo YH, Wang JL, Ge HL.

Chin Med J (Engl). 2008 May 20;121(10):887-91.

PMID:
18706201
14.

Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.

Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.

Arch Cardiovasc Dis. 2013 Nov;106(11):554-61. doi: 10.1016/j.acvd.2013.06.056. Epub 2013 Nov 11.

15.

Late and very late stent thrombosis in patients with second-generation drug-eluting stents.

Huang KN, Grandi SM, Filion KB, Eisenberg MJ.

Can J Cardiol. 2013 Nov;29(11):1488-94. doi: 10.1016/j.cjca.2013.04.001. Epub 2013 Jul 4. Review.

PMID:
23830291
16.

Long-term outcomes following very late stent thrombosis of drug-eluting stent.

Xu L, Sun H, Wang L, Li K, Zhang D, Chen M, Wang H, Li W, Ni Z, Xia K, Liu Y, Yang X.

J Cardiol. 2015 Dec;66(6):496-501. doi: 10.1016/j.jjcc.2014.11.014. Epub 2015 Apr 13.

17.

Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.

Bangalore S, Amoroso N, Fusaro M, Kumar S, Feit F.

Circ Cardiovasc Interv. 2013 Aug;6(4):378-90. doi: 10.1161/CIRCINTERVENTIONS.113.000415. Epub 2013 Aug 6. Erratum in: Circ Cardiovasc Interv. 2013 Dec;6(6):e80.

18.

Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.

Kersting S, Grumann T, Hummel J, Hauschke D, Bode C, Hehrlein C.

Crit Pathw Cardiol. 2012 Sep;11(3):152-9. doi: 10.1097/HPC.0b013e31825d267a.

PMID:
22825536
19.
20.

Supplemental Content

Support Center